Interleukin-15 and Interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

European Neurology

Volumn 63, Issue 5, 2010, Pages 285-290

  Rentzos, Michael ^a   Rombos, Antonis ^a   Nikolaou, Chryssoula ^a   Zoga, Margarita ^a   Zouvelou, Vassiliki ^a   Dimitrakopoulos, Antonis ^a   Alexakis, Theodoros ^a   Tsoutsou, Anthousa ^a   Samakovli, Anastasia ^a   Michalopoulou, Maria ^a   Evdokimidis, Ioannis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amyotrophic lateral sclerosis; Immune activation; Interleukin 12; Interleukin 15

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 15;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; PATHOGENESIS; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RATING SCALE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-15; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77950933850     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000287582     Document Type: Article

References (29)

1. Troost D, Van den Oord JJ, Vianney de Jong JM: Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1990; 16: 401-410.
2. Engelhardt JI, Tajti J, Appel SH: Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993; 50: 30-36.
3. Enghelhartdt JI, Appel SH: IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 1990; 47: 1210-1216.
4. Ono S, Hu J, Shimizu N, Imai T, Nakagawa H: Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci 2001; 187: 27-34.
5. Panzara MA, Gussoni E, Begovich AB, Murray RS, Zang YQ, Appel SH, et al: T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic multiple sclerosis. Neurobiol Dis 1999; 6: 392-405.
6. Sekizawa T, Openshaw H, Obbo K, Sugamura K, Itoyama Y, Niland JC: Cerebrospinal fluid interleukin-6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non inflammatory central nervous system diseases. J Neurol Sci 1998; 154: 194-199.
7. Holmy T, Roos PM, Kvale E: ALS: cytokine profile in cerebrospinal fluid T-cell clones. Amyotroph Lateral Scler 2006; 7: 183-186.
8. Ford L, Rowe D: Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 118-120.
9. Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, et al: Intrathecal upregulation of G-CSF and its neuroprotective actions on motor neurons in ALS. J Neuropathol Exp Neurol 2006; 65: 816-825.
10. Kuhle J, Lindberg RL, Regeniter A, Mehling M, Steck AJ, Kappos L, et al: Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol 2009; 16: 771-774.
11. Grabstein KH, Eisenmann J, Shanebeck K, Rauch C, Srinivasan S, Fung V, et al: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994; 264: 965-968. (Pubitemid 24196167)
12. Jonuleit H, Wiedemann K, Muller G, Degwert J, Hoppe U, Knop J, et al: Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells. J Immunol 1997; 160: 2610-2615.
13. Lee YB, Satoh J, Walker DG, Kim SU: Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 1996; 7: 1062-1066.
14. Doherty TM, Seder RA, Sher A: Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996; 156: 735-741.
15. Carson WE, Giri JG, Lindemann M, Linett ML, Ahdieh M, Paxton R, et al: IL-15 is a novel cytokine that activates human NK cells via components of IL-2 receptor. J Exp Med 1994; 180: 1395-1405.
16. Blanco-Jerez C, Plaza JF, Masjuan J, Orensanz LM, Alvarez-Cermeno JC: Increased levels of IL-15 mRNA in relapsing-remitting multiple sclerosis attacks. J Neuroimmunol 2002; 128: 90-94.
17. Losy J, Niezgoda A, Zaremba J: IL-15 is elevated in sera of patients with relapsingremitting multiple sclerosis. Folia Neuropathol 2002; 40: 151-153.
18. Rentzos M, Cambouri C, Rombos A, Nikolaou C, Anagnostouli M, Tsoutsou A, et al: IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci 2006; 241: 25-29. (Pubitemid 43112512)
19. Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Tsoutsou A, et al: Circulating interleukin-15 in dementia disorders. J Neuropsychiatry Clin Neurosci 2007; 19: 318-325.
20. Ma X, Trinchieri G: Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 2001; 79: 55-92.
21. Li J, Gran B, Zhang GX, Ventura ES, Siglienti I, Rostami A, et al: Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J Neurol Sci 2003; 215: 95-103.
22. Hensley K, Fedynyshyn J, Ferrell S, Floyd RA, Gordon B, Grammas P, et al: Message and protein-level elevation of tumor necrosis factorα (TNF-α ) and TNF-α modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol Dis 2003; 14: 74-80.
23. Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini TG, et al: Circulating levels of tumour necrosis factor- and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 2000; 287: 211-214.
24. Brooks M, Miller R, Swash M, Munsat T: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2000; 1: 293-299.
25. Cedarbaum J, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al: The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999; 169: 13-21.
26. Nagatsu T, Savada M: Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des 2005; 11: 999-1016.
27. Ilzecka J, Stelmasiak Z, Dobosz B: Transforming growth factor- 1 (TGF- 1) in patients with amyotrophic lateral sclerosis. Cytokine 2002; 20: 239-243.
28. Vladí A, Horvat G, Vukadin S, Sucí Z, Simaga S: Cerebrospinal fluid and serum protein levels of TNF-α , IL-6 and soluble IL-6 receptor (sIL-6Rgp80) in multiple sclerosis patients. Cytokine 2002; 20: 86-89.
29. Holmoy T: T cells in amyotrophic lateral sclerosis. Eur J Neurol 2008; 15: 360-366.